Bayer links with DKSH to expand in Singapore

10 September 2013

DKSH Business Unit Healthcare, a leading partner for health care companies seeking to grow their business in Asia, has signed an agreement with Bayer Thai, a unit of Germany’s Bayer group (BAYN: DE), to provide services for Bayer’s products in Singapore.

Bayer already has significant investment in Singapore. In January 2013, Bayer HealthCare and five research institutions in Singapore set up a new Integrated Translational Oncology Network to further enhance R&D collaborations in the fight against the growing cancer burden in the Asia Pacific region. The establishment of the Network was supported and facilitated by the Singapore Economic Development Board (EDB).

DKSH Healthcare already provides market expansion services for Bayer’s Consumer Care and Pharmaceuticals Divisions in Thailand, China and Cambodia.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK